Explore our world-class manufacturing facilities across India, equipped with state-of-the-art technology and global regulatory approvals
Shilpa Medicare operates 6 state-of-the-art manufacturing facilities across India, each designed to meet the highest international quality standards and equipped with cutting-edge technology for pharmaceutical manufacturing.
Our facilities are strategically located and specialized to serve different segments of pharmaceutical manufacturing, from API production to finished dosage formulations. Each unit operates under strict cGMP guidelines and holds multiple international regulatory approvals including USFDA, EMA, and WHO-GMP.
Click on any facility to learn more about its capabilities and specializations
All our manufacturing facilities are approved by major regulatory authorities worldwide including USFDA, EMA, WHO-GMP, TGA, and multiple other international agencies. We maintain the highest standards of quality, safety, and compliance across all operations.
Complete range from small molecules to complex peptides and HPAPIs with advanced containment
Solid, liquid, and specialized dosage forms with novel drug delivery technologies
Comprehensive analytical and bioanalytical testing with latest instrumentation
Multiple international regulatory approvals and certifications
Integrated R&D support at manufacturing sites for continuous improvement
Green chemistry practices and environmental management systems
Each facility is designed with a focus on operational excellence, safety, and environmental responsibility. We continuously invest in upgrading our infrastructure, adopting new technologies, and training our workforce to maintain our position as a leading pharmaceutical manufacturer.
